KangaBio
PrivateLast Round
VC Round
Nov 1, 2025
Total Funding Raised
$26M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
KangaBio operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a VC Round in November 2025.
KangaBio is a biopharmaceutical company that specializes in the discovery and development of novel cancer immunotherapies, including prodrugs of immune agonists and multispecific antibodies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
KangaBio Comparables
Compare KangaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CytomX Therapeutics | 83% | |
| Bonum Therapeutics | 83% | |
| Audax Biosciences | 83% |
For institutional investors. Book with your work email.
KangaBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 1, 2025 | ||||
| Early Funding | Jun 23, 2023 | ||||
| Angel | Aug 1, 2021 |
For institutional investors. Book with your work email.
KangaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tianjin TEDA Science and Technology Investment Co., Ltd. | Early Funding |
| Daoyuan Capital | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
$15M raised in a VC Round.
- Aug 1, 2021
$11M raised in an angel round.
For institutional investors. Book with your work email.
KangaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about KangaBio's valuation, stock price, and market status.
Is KangaBio a public or private company?
KangaBio is a private company.
What is the current stock price of KangaBio?
KangaBio is a private company, so its shares have no public market price. Caplight tracks KangaBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is KangaBio worth (valuation)?
Valuation information for KangaBio is not publicly available.
Can I buy KangaBio stock?
KangaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was KangaBio's last funding round?
KangaBio's most recent funding round was VC Round on November 1, 2025.
Who are the main investors in KangaBio?
Key investors in KangaBio include Daoyuan Capital.
Will KangaBio IPO soon?
No public IPO plans have been announced for KangaBio.
How can I track KangaBio secondary market activity?
Caplight tracks bids, offers, and trades in KangaBio's shares on secondary markets.